Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis

Total article views   HTML views PDF downloads Totals
15,657 Dovepress* 15,657+ 3,467 19,124
Totals 15,657 3,467 19,124
*Since 12 April 2010
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 0 6

View citations on Google Scholar